The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.
 
Philipp Mandel
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Ipsen; Johnson & Johnson/Janssen; MSD; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Bayer; Johnson & Johnson/Janssen; Novartis
 
Benedikt Hoeh
No Relationships to Disclose
 
Carolin Siech
No Relationships to Disclose
 
Florestan Koll
No Relationships to Disclose
 
Clara Humke
No Relationships to Disclose
 
Daniel Groener
Honoraria - Sanofi Aventis GmbH
 
Thomas Steuber
Honoraria - Astellas Pharma; Bayer; J&J; Novartis
Consulting or Advisory Role - Astellas Pharma; Johnson & Johnson/MedTech
 
Markus Graefen
Honoraria - Astellas Pharma; Bayer; Janssen; Medtronic; Takeda
Consulting or Advisory Role - Medtronic
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Takeda
 
Tobias Maurer
No Relationships to Disclose
 
Severine Banek
No Relationships to Disclose
 
Felix Chun
No Relationships to Disclose
 
Mike Wenzel
Honoraria - Accord Healthcare; AstraZeneca; Ipsen; Johnsen&Johnsen; MSD; MSD; Pfizer